Eli Lilly to acquire Seattle-area vaccine maker for $1.5 billion - The Seattle Times
Eli Lilly to acquire Seattle-area vaccine maker for $1.5 billion The Seattle Times Healthy Returns: Eli Lilly makes a new push into vaccines – here’s what to know CNBC Lilly Goes on $20 Billion Buying Spree as Company Seeks Next Act Bloomberg.com Lilly announces three acquisitions to build infectious disease portfolio | Eli Lilly and Company investor.lilly.com Three vaccine biotechs to be bought by Lilly for up to $3.8B Endpoints News
YesNo saves this item as an on-site live signal so search users can understand how it connects to prediction markets and incubation topics.
If later reporting creates a clear deadline, official source, or verifiable outcome, the public event can become a tradable Yes/No question.
This item has a verifiable event angle that can be monitored for a Yes/No prediction market.